CAS: 1365888-06-7
![2-Propenoic acid, 3-[4-[(1E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)-1-buten-1-yl]phenyl]-, (2E)-](https://static.cymitquimica.com/products/AN/thumb/AG00123J.jpg)
2-Propenoic acid, 3-[4-[(1E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)-1-buten-1-yl]phenyl]-, (2E)-
CAS:1365888-06-7
Formula:
C26H20ClFN2O2
Purity:
98+%
Color and Shape:
Solid
Molecular weight:
446.9006
Ref: AN-AG00123J
| 5mg | 88.00 € | |
| 10mg | 120.00 € | |
| 25mg | 169.00 € | |
| 50mg | 284.00 € |
Estimated delivery in United States, on Thursday 2 May 2024
Ref: 4Z-B-170001
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 8 May 2024
Brilanestrant
CAS:1365888-06-7
Brilanestrant (GDC-0810) is a selective estrogen receptor degrader (IC50: 0.7 nM).
Formula:
C26H20ClFN2O2
Purity:
98.71%
Color and Shape:
Solid Powder
Molecular weight:
446.9
Ref: TM-T5118
| 1mg | 52.00 € | |
| 2mg | 75.00 € | |
| 5mg | 104.00 € | |
| 10mg | 147.00 € | |
| 25mg | 254.00 € | |
| 50mg | 421.00 € | |
| 100mg | 605.00 € | |
| 1ml*10 (DMSO) | 124.00 € |
Estimated delivery in United States, on Wednesday 8 May 2024
GDC 0810
CAS:1365888-06-7
Estrogen receptor degrader; therapeutic use in breast cancer
Formula:
C26H20ClFN2O2
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
446.9 g/mol
Ref: 3D-FG137678
| 5mg | 120.00 € | |
| 10mg | 184.00 € | |
| 25mg | 324.00 € | |
| 50mg | 457.00 € | |
| 100mg | 678.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
